Clinical Trial Update: A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated atezolizumab with or without bevacizumab in combination with cisplatin and gemcitabine for untreated, advanced biliary tract cancer. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-29